PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 8, 2026Diabetology0 citationsOpen Access

Oxygen-Enriched Oil-Based Dressing: A New Option for Tunneling Post-Surgical Diabetic Foot Ulcers

View Full Paper
ASAlessia ScatenaSSSara SandroniMAMatteo Apicella

Key Points

  • This study evaluates the effectiveness of an oxygen-enriched oil-based device in facilitating the healing of post-surgical diabetic foot ulcers.
  • Prospective controlled comparative pilot study
  • Enrolled 40 patients with diabetes mellitus and post-surgical foot wounds
  • Divided into two groups: standard wound care and oxygen-enriched oil-based device treatment
  • 85% complete wound healing in OEOd group versus 45% in control (p = 0.020)
  • 89.8% wound area reduction in OEOd group compared to 64.0% in control at 16 weeks (p = 0.013)
  • Infection rates and need for re-intervention favored OEOd group but were not statistically significant

Abstract

Background: Postoperative wounds may arise from several etiologies, including open partial pedal amputation, postoperative infection, and dehiscence of surgical sites from wound failure or patient compliance issues. If negative pressure wound therapy is the gold standard, its application in the toes area could be challenging, and as a consequence, standard care is most likely used. The control of the wound microenvironment, both in terms of pH levels and presence of reactive oxygen species, is a key part of the normal wound-healing process. This study evaluated the effectiveness of an oxygen-enriched oil-based device (OEOd) in post-surgical diabetic foot ulcers (DFUs). Methods: This prospective controlled comparative pilot study enrolled 40 patients with diabetes mellitus and post-surgical foot wounds (narrow and deep lesions, including tunneling ulcers) treated at the Diabetic Foot Unit of San Donato Hospital, Arezzo (March 2024–April 2025). Patients were allocated into two groups: those treated by the standard wound care (n = 20) and those treated by OEOd (n = 20). The primary outcome was complete wound healing at 16 weeks; other exploratory endpoints were wound area reduction at 4 and 16 weeks, onset of infection, need for re-intervention, and adverse events. Results: Complete wound healing was achieved in 85.0% of OEOd patients versus 45.0% in the control group (p = 0.020). At 16 weeks, wound area reduction was significantly greater in the OEOd group compared with standard therapy (89.8% vs. 64.0%, p = 0.013). Although infection rates (10.0% vs. 35.0%, p = 0.130) and need for re-intervention (0% vs. 25.0%, p = 0.056) did not reach statistical significance, both favored the OEOd group. No adverse events were reported. Conclusions: OEOd significantly improved the chance of healing post-surgery and showed favorable trends in reducing complications, with an excellent safety profile. Larger randomized controlled trials are warranted to confirm these findings and assess long-term outcomes.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Scatena et al. (2026) studied this question.

synapsesocial.com/papers/69acc59c32b0ef16a40501cdhttps://doi.org/10.3390/diabetology7030055
Ask AI
Helpful
Bookmark
Share
View Full Paper